Close
Help
Need Help?





JOURNAL

Cancer Growth and Metastasis

59,652 Journal Article Views | Journal Analytics

Serum YKL-40 Levels in Patients with Esophageal Squamous Cell Carcinoma

Submit a Paper



Publication Date: 04 Apr 2011

Type: Original Research

Journal: Cancer Growth and Metastasis

Citation: Cancer Growth and Metastasis 2011:4 1-5

doi: 10.4137/CGM.S7046

Abstract

Aims and background: YKL-40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. YKL-40 is expressed and secreted by several types of tumors. The aim of this study examined the clinical usefulness of YKL-40 for detection in esophageal squamous cell carcinoma (ESCC).

Methods: Using ELISA kits, we measured the concentration of YKL-40 in serum from 100 patients with ESCC and compared this concentration with healthy population.

Results: We found significantly higher serum levels of YKL-40 in patients with ESCC compared to the healthy population

(P < 0.0001).

Conclusions: These results suggested that regarding serum YKL-40 as a tumor marker could be benefical in the early clinical diagnosis.


Downloads

PDF  (599.20 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)




Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Cancer Growth and Metastasis
My experience with the review stages and manuscript processing in Cancer Growth and Metastasis has been of excellence. The fine balance of times utilized for proper scientific assessment of the material and quality control is greatly commended.
Dr Carlos Telleria (Sanford School of Medicine of The University of South Dakota, Vermillion, SD, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results